Advisors Asset Management Inc. Sells 304 Shares of Humana Inc. (NYSE:HUM)

Advisors Asset Management Inc. reduced its stake in Humana Inc. (NYSE:HUM) by 8.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,171 shares of the insurance provider’s stock after selling 304 shares during the period. Advisors Asset Management Inc.’s holdings in Humana were worth $1,004,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Mendota Financial Group LLC boosted its stake in shares of Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 27 shares in the last quarter. Capital Advisors Ltd. LLC raised its holdings in Humana by 17.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after buying an additional 31 shares during the last quarter. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the period. Harbour Investments Inc. increased its position in Humana by 10.5% in the 2nd quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after acquiring an additional 41 shares during the period. Finally, Baader Bank Aktiengesellschaft increased its position in Humana by 1.0% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider’s stock valued at $1,649,000 after acquiring an additional 42 shares during the period. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Truist Financial reduced their price objective on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research note on Friday, October 11th. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. KeyCorp initiated coverage on Humana in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Oppenheimer decreased their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $315.86.

Humana Price Performance

Shares of HUM opened at $295.49 on Wednesday. The business’s fifty day moving average is $276.28 and its 200 day moving average is $330.23. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market cap of $35.58 billion, a P/E ratio of 26.17, a P/E/G ratio of 2.35 and a beta of 0.52.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Sell-side analysts anticipate that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.20%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.